·¹ºñÇÁ¸ÖƼµµÁîÄ«Æ®¸®Áö66¸¶ÀÌÅ©·Î±×·¥(ÀçÁ¶ÇÕÀΰ£ÀÎÅÍÆä·Ðº£Å¸1a, À¯ÀüÀÚÀçÁ¶ÇÕ)
¾÷ü¸í : ¸ÓÅ©(ÁÖ)
È¿´ÉÈ¿°ú
ÀÓ»óÀû µ¶¸³ÁõÈıº(Clinically Isolated Syndrome, CIS, First clinical demyelinating event)ÀÇ Ä¡·á. ´Ù¸¥ ÁúȯÀ¸·Î Áø´ÜµÇÁö ¾ÊÀ¸¸ç, ÀÓ»óÀû È®Áø ´Ù¹ß¼º °æÈÁõ (Clinically Definite Multiple Sclerosis, CDMS)À¸·Î ÁøÇàµÉ À§ÇèÀÌ ³ôÀº °æ¿ì·Î Á¤ÀÇÇÏ¿´´Ù.
Àç¹ß¼º ´Ù¹ß¼º °æÈÁõÀÇ Ä¡·á. ´Ü ÀÓ»ó½ÃÇè¿¡¼´Â Àç¹ß¼ºÀÇ Á¤ÀǸ¦ Áö³ 2³â µ¿¾È 2ȸ ÀÌ»ó Áõ»óÀÇ ±Þ¼º ¾ÇÈ·Î Á¤ÀÇÇÏ¿´´Ù.
ÀÌÂ÷Àû ÁøÇ༺ ´Ù¹ß¼º °æÈÁõ(Secondary Progressive Multiple Sclerosis, SPMS) ȯÀÚÀÇ °æ¿ì, ÁøÇ༺ Àç¹ß È°¼ºÀÌ ¾ø´Â ȯÀÚ¿¡ ´ëÇؼ´Â À¯È¿¼ºÀÌ ÀÔÁõµÇÁö ¸øÇÏ¿´´Ù.
½ÄÇ°ÀǾà¾ÈÁ¤Ã»¿¡¼ ¿ë·®¿ë¹ý ¹× »ç¿ë»ó ÁÖÀÇ»çÇ× ¾Ë¾Æº¸±â
https://ezdrug.mfds.go.kr/#!CCBAA03F010